COVID-19 pandemic helped India to scale up its healthcare infrastructure, says ICMR DG

By ANI | Published: February 3, 2021 08:12 PM2021-02-03T20:12:51+5:302021-02-03T20:20:03+5:30

While India has been successful in controlling the Covid-19 pandemic, it also turned out to be a huge opportunity for the country to scale up its healthcare infrastructure, said Director General of the Indian Council of Medical Research (ICMR) Balram Bhargava on Wednesday.

COVID-19 pandemic helped India to scale up its healthcare infrastructure, says ICMR DG | COVID-19 pandemic helped India to scale up its healthcare infrastructure, says ICMR DG

COVID-19 pandemic helped India to scale up its healthcare infrastructure, says ICMR DG

While India has been successful in controlling the Covid-19 pandemic, it also turned out to be a huge opportunity for the country to scale up its healthcare infrastructure, said Director General of the Indian Council of Medical Research (ICMR) Balram Bhargava on Wednesday.

Speaking to , Bhargava said that the pandemic is under control in the country as the government adopted a science-driven approach.

"We innovated from using molecular tests very early. The pandemic turned out to be a huge opportunity for India to scale up its healthcare infrastructure," he said.

"A 'jan-andolan' for masking, a 'jan-andolan'for 'do gaj ki duri' and a 'jan-andolan' for hand hygiene was the top-down government approach that has helped the country and now we are seeing such low numbers of cases," he said.

Bhargava said that the ICMR worked on testing and vaccine and also scaled up from a single lab to 2,500 labs. "We innovated from using molecular tests very early," he added.

"As compared to Western and other countries' approach, we took the pandemic seriously from the beginning. We adopted the 5 Ts strategy of testing, tracking, tracing, technology, treating very early," the DG said.

Bhargava also advised people to continue the COVID-appropriate behaviours of wearing masks, maintaining social distancing and following health hygiene as the herd immunity is still far.

Regarding the vaccine hesitancy among the people, he said that the machinery is robust in terms of vaccine manufacture, delivery, and safety.

"In terms of Covid-19 vaccines, we have rapidly developed these two vaccines, which are very safe. They have been tested on large populations in India and some other parts of the world," informed Bhargava.

Two COVID-19 vaccines- Covishield of AstraZeneca and Oxford University and Bharat Biotech's Covaxin have been granted emergency use authorisation in the country. The vaccination drive in the country began on January 16.

"We have nearly vaccinated 50 percent of our healthcare workers," he added.

As on February 3, 2021, till 8 am, more than 41 lakh (41,38,918) beneficiaries have received the vaccination under the countrywide COVID19 vaccination exercise.

Commenting on the recent union budget, the ICMR DG said that the budget was great from the point of view of the healthcare infrastructure.

"This has been hugely demonstrated in the budget that healthcare is the top priority. We also have to think of the unfinished agenda for the country's health and eliminate certain alienable diseases," he said.

Bhargava further said that the next focus of the country would be on malaria, tuberculosis and leprosy.

"Many of them have to be eliminated in the next decade or so. The non-communicable disease like diabetes, hypertension, etc can be tackled by lifestyle modification," he said.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in app